Home > Insider Trading > Filing (0001940272-24-000006)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583648	Pieris Pharmaceuticals Inc.	PIRS	Pharmaceutical Preparations (2834)	300784346

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1758866	Adar1 Partners, Lp	3503 Wild Cherry Drive Building 9 Austin TX 78738		No	No	Yes	No
1940272	Adar1 Capital Management, Llc	3503 Wild Cherry Drive Building 9 Austin TX 78738		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-08-09	3,000	$14.89	127,331	No	4	P	Indirect	By: ADAR1 Partners
Common Stock	Acquisiton	2024-08-12	2,243	$15.88	129,574	No	4	P	Indirect	By: ADAR1 Partners
Common Stock	Acquisiton	2024-08-12	757	$15.88	15,067	No	4	P	Indirect	By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By: ADAR1 Partners
No	4	P	Indirect	By: ADAR1 Partners
No	4	P	Indirect	By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1

Footnotes

ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP ("ADAR1 Partners"). Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by Spearhead Insurance Solutions IDF, LLC - Series ADAR1 ("Spearhead"). Because of the relationship between Spearhead and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by Spearhead.
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.